This research study evaluates the concordance of the result between two diagnostic tests: Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with ovarian cancer.
The objective of this study is to describe the feasibility of performing the sentinel node technique (Detection rate) in patients with early stage ovarian cancer. With this research study it will be evaluated the concordance of the result between two diagnostic tests: Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with ovarian cancer.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
20
Injection of a tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.
Hospital Universitario y Politécnico La Fe
Valencia, Spain
Feasibility of performing the sentinel node technique (Detection rate)
The objective of this study is to describe the feasibility of performing the sentinel node technique (Detection rate) in patients with previous ovarian surgery injecting the tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.
Time frame: Intraoperative (day 0)
Rate of realization of the technique
Time frame: Intraoperative (day 0)
Rate of realization of the technique
Time frame: After anatomopathological study (day 30)
Anatomical location of the sentinel node(s)
Assessed by radiation (99Tc-nanocoloides) and staining with indocyanine green
Time frame: Intraoperative (day 0)
Anatomical location of the sentinel node(s)
Assessed by the pathologist
Time frame: After anatomopathological study (day 30)
Number of detected sentinel nodes
Time frame: Intraoperative (day 1)
Number of detected sentinel nodes
Time frame: After anatomopathological study (day 30)
Characterization of the sample by collecting baseline characteristics
Age (years)
Time frame: Screening (day 0)
Characterization of the sample by collecting baseline characteristics
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Weight (kilograms)
Time frame: Screening (day 0)
Characterization of the sample by collecting baseline characteristics
Height (centimeters)
Time frame: Screening (day 0)
Characterization of the sample by collecting baseline characteristics
BMI (kg/m\^2)
Time frame: Screening (day 0)
Characterization of the sample by collecting baseline characteristics
Previous gynecological surgery and previous pathological anatomy
Time frame: Screening (day 0)
Characterization of the sample by collecting tumor markers
Ca 125 and Ca 19.9.
Time frame: Day 0
Characterization of the sample by collecting intraoperative findings
Ascites (milliliters)
Time frame: Day 0
Characterization of the sample by collecting intraoperative findings
Tumor size (centimeters) of: right ovary, left ovary, right tube, left tube, uterus, pelvic nodes, para-aortic nodes, and tumor in upper hemiabdomen.
Time frame: Day 0
Characterization of the sample by collecting surgical procedures
Hysterectomy, adnexectomy, appendectomy, peritonectomy / peritoneal biopsy, omentectomy, lymphadenectomy and blood transfusion (Realized or Unrealized)
Time frame: Day 0
Characterization of the sample by collecting surgical procedures
Intraoperative complications
Time frame: Day 0
Characterization of the sample by collecting surgical procedures
Result of intraoperative biopsy (unrealized, malignant, benign)
Time frame: Day 0
Characterization of the sample by collecting surgical procedures
Estimated blood loss (milliliters)
Time frame: Day 0
Characterization of the sample by collecting surgical procedures
Surgical time (minutes)
Time frame: Day 0